- You can view the full AstraZeneca Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Jefferies increased AstraZeneca's (AZN) stock rating to 'buy' this morning.
The drug company has several generic drugs that will compete with the likes of Pfizer's Viagra and Valeant's Acanya.
So says a proxy filing made after trading on Tuesday, as a couple of suitors included contingent value rights in their bids for the marketer of prostate cancer drug, Xtandi.